Company · CIK 1850902

# Alpha Teknova, Inc.

| CIK | [1850902](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001850902) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2835 — In Vitro & In Vivo Diagnostic Substances |
| Incorporated in | DE |
| Business address | CA |
| Listed | TKNO (Nasdaq) |
| First annual or quarterly report | 2021-08-13 |

## Offerings

 5 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-288613 | Shelf Effective | 2025-07-10 | 2026-10-21 | 4 |
| 333-281765 | Registered company Effective | 2024-08-23 | 2024-08-29 | 2 |
| 333-275168 | Registered company Effective | 2023-10-25 | 2023-11-07 | 2 |
| 333-265987 | Shelf Effective | 2022-07-01 | 2023-09-19 | 4 |
| 333-256795 | IPO Final prospectus | 2021-06-04 | 2021-06-25 | 4 |

## Filings

 17

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-10-21 | [424B5](https://www.sec.gov/Archives/edgar/data/1850902/000119312526427916/0001193125-26-427916-index.htm) Shelf takedown | 333-288613 | 0001193125-26-427916 |
| 2026-10-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1850902/000119312526426674/0001193125-26-426674-index.htm) Shelf takedown | 333-288613 | 0001193125-26-426674 |
| 2025-07-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1850902/999999999525002267/9999999995-25-002267-index.htm) Declared effective | 333-288613 | 9999999995-25-002267 |
| 2025-07-10 | [S-3](https://www.sec.gov/Archives/edgar/data/1850902/000119312525157628/0001193125-25-157628-index.htm) Shelf registered | 333-288613 | 0001193125-25-157628 |
| 2024-08-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1850902/999999999524002690/9999999995-24-002690-index.htm) Declared effective | 333-281765 | 9999999995-24-002690 |
| 2024-08-23 | [S-1](https://www.sec.gov/Archives/edgar/data/1850902/000119312524206239/0001193125-24-206239-index.htm) Registration filed | 333-281765 | 0001193125-24-206239 |
| 2023-11-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1850902/999999999523003237/9999999995-23-003237-index.htm) Declared effective | 333-275168 | 9999999995-23-003237 |
| 2023-10-25 | [S-1](https://www.sec.gov/Archives/edgar/data/1850902/000119312523263115/0001193125-23-263115-index.htm) Registration filed | 333-275168 | 0001193125-23-263115 |
| 2023-09-19 | [424B5](https://www.sec.gov/Archives/edgar/data/1850902/000119312523237665/0001193125-23-237665-index.htm) Shelf takedown | 333-265987 | 0001193125-23-237665 |
| 2023-03-30 | [424B5](https://www.sec.gov/Archives/edgar/data/1850902/000119312523085766/0001193125-23-085766-index.htm) Shelf takedown | 333-265987 | 0001193125-23-085766 |
| 2022-07-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1850902/999999999522002044/9999999995-22-002044-index.htm) Declared effective | 333-265987 | 9999999995-22-002044 |
| 2022-07-01 | [S-3](https://www.sec.gov/Archives/edgar/data/1850902/000119312522187223/0001193125-22-187223-index.htm) Shelf registered | 333-265987 | 0001193125-22-187223 |
| 2021-06-25 | [424B4](https://www.sec.gov/Archives/edgar/data/1850902/000119312521200510/0001193125-21-200510-index.htm) Final prospectus | 333-256795 | 0001193125-21-200510 |
| 2021-06-24 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1850902/999999999521002500/9999999995-21-002500-index.htm) Declared effective | 333-256795 | 9999999995-21-002500 |
| 2021-06-21 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1850902/000119312521194075/0001193125-21-194075-index.htm) Amendment | 333-256795 | 0001193125-21-194075 |
| 2021-06-04 | [S-1](https://www.sec.gov/Archives/edgar/data/1850902/000119312521182919/0001193125-21-182919-index.htm) Registration filed | 333-256795 | 0001193125-21-182919 |
| 2021-04-05 | [DRS](https://www.sec.gov/Archives/edgar/data/1850902/000095012321004208/0000950123-21-004208-index.htm) Draft made public | 377-04587 | 0000950123-21-004208 |

[All filings of this company](https://equitycapital.markets/filings?cik=1850902) · [CSV](https://equitycapital.markets/filings.csv?cik=1850902)

---
Source page: https://equitycapital.markets/company/1850902 · Data: U.S. SEC EDGAR · CC BY 4.0